REPLIGEN CORP (RGEN) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $564.00K; Additional Paid in Capital, Common StockUSD $1.66B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $564.00K; Additional Paid in Capital, Common StockUSD $1.65B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $563.00K; Additional Paid in Capital, Common StockUSD $1.65B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $563.00K; Additional Paid in Capital, Common StockUSD $1.64B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
REPLIGEN CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $564.00K | $1.66B | (m) | $-19.79M | $469.59M | $2.11B | (m) | 3 month · $8.01M 6 month · $16.34M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $564.00K | $1.65B | (m) | $-14.31M | $464.58M | $2.11B | (m) | 3 month · $8.32M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $563.00K | $1.65B | (m) | $-2.53M | $456.25M | $2.11B | (m) | 12 month · $32.60M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $563.00K | $1.64B | (m) | $-4.11M | $442.96M | $2.08B | (m) | 3 month · $8.97M 9 month · $24.62M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $563.00K | $1.63B | (m) | $-1.72M | $428.05M | $2.06B | (m) | 3 month · $8.38M 6 month · $15.65M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $562.00K | $1.62B | (m) | $-47.84M | $413.18M | $1.99B | (m) | 3 month · $7.27M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $561.00K | $1.62B | $-14.72M | $-52.53M | $407.35M | $1.97B | (m) | 12 month · $48.07M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $560.00K | $1.61B | $3.19M | $-34.62M | $441.22M | $2.02B | (m) | 3 month · $23.05M 9 month · $41.71M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $559.00K | $1.59B | $9.82M | $-44.45M | $441.88M | $1.98B | (m) | 3 month · $9.88M 6 month · $18.66M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $559.00K | $1.57B | $-5.13M | $-42.94M | $436.16M | $1.97B | (m) | 3 month · $8.78M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $558.00K | $1.57B | $-3.41M | $-37.81M | $432.87M | $1.96B | (m) | 12 month · $25.57M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $558.00K | $1.57B | (m) | $-43.37M | $449.32M | $1.97B | (m) | 3 month · $6.37M 9 month · $19.11M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $557.00K | $1.56B | $-6.38M | $-37.49M | $432.39M | $1.96B | (m) | 3 month · $5.48M 6 month · $12.74M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $556.00K | $1.54B | $2.99M | $-31.41M | $412.61M | $1.93B | (m) | 3 month · $7.25M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $556.00K | $1.55B | $-17.51M | $-34.39M | $397.27M | $1.91B | 3 month · $100.00M | 12 month · $27.32M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $555.00K | $1.54B | (m) | $-55.26M | $348.54M | $1.84B | (m) | 3 month · $6.15M 9 month · $21.05M | 3 month · $105.00K | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $555.00K | $1.53B | $-18.17M | $-37.09M | $308.14M | $1.81B | (m) | 3 month · $6.99M 6 month · $14.90M | 3 month · $-82.00K 6 month · $-105.00K | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $554.00K | $1.53B | $-4.69M | $-21.57M | $258.28M | $1.77B | (m) | 3 month · $7.92M | 3 month · $-24.00K | (m) | (m) | (m) | (m) |
| 2022-01-01 | (m) | (m) | (m) | (m) | (m) | $17.30M | (m) | (m) | (m) | (m) | $39.10M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $553.00K | $1.57B | $-18.97M | $-16.89M | $194.06M | $1.75B | (m) | 12 month · $27.50M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $553.00K | $1.56B | (m) | $-9.92M | $164.95M | $1.72B | (m) | 3 month · $6.79M 9 month · $20.48M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $550.00K | $1.48B | $-5.55M | $-4.37M | $131.45M | $1.60B | (m) | 3 month · $7.14M 6 month · $13.68M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $549.00K | $1.47B | $3.12M | $-7.49M | $95.22M | $1.56B | (m) | 3 month · $6.54M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $548.00K | $1.46B | $17.11M | $2.08M | $65.77M | $1.53B | (m) | 12 month · $17.01M | (m) | (m) | (m) | 12 month · $400.00K | (m) |
| 2020-09-30 | (m) | $526.00K | $1.09B | (m) | $-9.72M | $46.07M | $1.12B | (m) | 3 month · $4.22M 9 month · $12.49M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $525.00K | $1.08B | $4.39M | $-14.11M | $31.52M | $1.10B | (m) | 3 month · $4.10M 6 month · $8.27M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $523.00K | $1.07B | $6.49M | $-20.61M | $15.66M | $1.07B | (m) | 3 month · $4.17M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $521.00K | $1.07B | $-3.13M | $-15.03M | $5.84M | $1.06B | (m) | 12 month · $12.85M | (m) | (m) | 12 month · $39.07M | 12 month · $18.61M | (m) |
| 2019-09-30 | (m) | $521.00K | $1.06B | (m) | $-21.79M | $2.24M | $1.05B | (m) | 3 month · $3.17M 9 month · $9.46M | (m) | (m) | 3 month · $38.09M 9 month · $38.09M | 3 month · $6.98M 9 month · $18.61M | (m) |
| 2019-06-30 | (m) | $481.00K | $892.96M | $-6.74M | $-15.05M | $580.00K | $878.97M | (m) | 3 month · $3.03M 6 month · $6.28M | (m) | (m) | (m) | 3 month · $500.00K 6 month · $500.00K | (m) |
| 2019-03-31 | (m) | $441.00K | $645.88M | $-1.27M | $-13.78M | $-7.51M | $625.02M | (m) | 3 month · $3.25M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $439.00K | $642.59M | $-5.53M | $-11.89M | $-677.00K | $615.57M | (m) | 12 month · $10.19M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $439.00K | $639.03M | (m) | $-11.77M | $-21.21M | $606.49M | (m) | 3 month · $2.78M 9 month · $7.67M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $438.00K | $635.36M | $-630.00K | $-11.14M | $-26.00M | $598.66M | (m) | 3 month · $2.62M 6 month · $4.89M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $437.00K | $631.60M | $-5.03M | $-6.11M | $-28.74M | $597.18M | (m) | 3 month · $2.27M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $436.00K | $628.98M | $7.38M | $-6.36M | $-31.51M | $591.55M | (m) | 12 month · $6.75M | (m) | (m) | (m) | 12 month · $8.69M | (m) |
| 2017-09-30 | (m) | $436.00K | $626.77M | (m) | $-6.65M | $-43.69M | $576.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $341.00K | $247.63M | (m) | $-8.67M | $-48.35M | $190.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $341.00K | $245.96M | (m) | $-12.72M | $-56.79M | $176.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $338.00K | $242.04M | $-5.19M | $-13.75M | $-59.86M | $168.76M | (m) | 12 month · $4.59M | (m) | (m) | 12 month · $6.51M | 12 month · $639.00K | 12 month · $18.07M |
| 2016-09-30 | (m) | $338.00K | $240.57M | (m) | $-9.50M | $-64.89M | $166.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $337.00K | $238.62M | (m) | $-9.18M | $-66.05M | $163.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $331.00K | $205.14M | (m) | $-6.67M | $-69.92M | $128.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $329.00K | $202.53M | (m) | $-8.57M | $-71.54M | $122.75M | (m) | 12 month · $3.60M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $329.00K | $201.66M | (m) | $-8.73M | $-71.81M | $121.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $329.03K | $200.44M | (m) | $-8.20M | $-74.35M | $118.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $328.51K | $199.20M | (m) | $-9.64M | $-77.96M | $111.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $328.00K | $198.06M | (m) | $-5.77M | $-80.89M | $111.73M | (m) | 12 month · $1.77M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $327.03K | (m) | (m) | $-2.72M | $-80.49M | $114.59M | (m) | (m) | (m) | $197.47M | (m) | (m) | (m) |
| 2014-06-30 | $0.00 | $326.59K | (m) | (m) | $404.64K | $-81.95M | $115.56M | (m) | (m) | (m) | $196.78M | (m) | (m) | (m) |
| 2014-03-31 | (m) | $320.41K | (m) | (m) | $1.86M | $-84.78M | $108.85M | (m) | (m) | (m) | $191.45M | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $319.26K | $190.63M | (m) | $2.00M | $-89.06M | $84.12M | (m) | 12 month · $1.06M | (m) | $190.63M | (m) | (m) | (m) |
| 2013-09-30 | (m) | $318.83K | (m) | (m) | $2.17M | $-92.38M | $100.16M | (m) | (m) | (m) | $190.05M | (m) | (m) | (m) |
| 2013-06-30 | (m) | $318.14K | (m) | (m) | $764.85K | $-98.27M | $92.45M | (m) | (m) | (m) | $189.64M | (m) | (m) | (m) |
| 2013-03-31 | (m) | $314.25K | (m) | (m) | $1.86M | $-102.81M | $87.41M | (m) | (m) | (m) | $188.26M | (m) | (m) | (m) |
| 2012-12-31 | (m) | $311.95K | (m) | (m) | $2.00M | $-105.15M | $84.12M | (m) | 12 month · $1.02M | (m) | $187.05M | (m) | (m) | (m) |
| 2012-09-30 | (m) | $310.55K | (m) | (m) | $1.58M | $-114.69M | $73.70M | (m) | (m) | (m) | $186.50M | (m) | (m) | (m) |
| 2012-06-30 | (m) | $308.46K | (m) | (m) | $-527.68K | $-116.51M | $68.73M | (m) | (m) | (m) | $185.46M | (m) | (m) | (m) |
| 2012-03-31 | (m) | $308.36K | (m) | (m) | $1.20M | $-118.07M | $68.67M | (m) | (m) | (m) | $185.23M | (m) | (m) | (m) |
| 2011-12-31 | (m) | $307.15K | (m) | (m) | $113.63K | $-119.31M | $65.99M | (m) | 9 month · $730.14K 12 month · $730.14K | (m) | $184.87M | (m) | (m) | (m) |
| 2011-09-30 | (m) | $307.15K | (m) | (m) | $2.69K | $-117.14M | $67.83M | (m) | (m) | (m) | $184.67M | (m) | (m) | (m) |
| 2011-06-30 | (m) | $308.12K | (m) | (m) | (m) | $-118.02M | $67.31M | (m) | (m) | (m) | $185.03M | (m) | (m) | (m) |
| 2011-03-31 | (m) | $308.12K | (m) | (m) | (m) | $-117.96M | $67.09M | (m) | 12 month · $1.00M | (m) | $184.74M | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $67.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $66.12M | (m) | 12 month · $1.01M | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $69.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |